HZB & IKZ bundle their competencies In crystalline energy and quantum materials

The participants after signing the cooperation agreement between IKZ and HZB in corona-conform distance: (from left to right) Dr. Andreas Popp (IKZ), Dr. Manuela Urban (FVB), Dr. Peter Gaal (IKZ), Prof. Dr. Catherine Dubourdieu (HZB), Prof. Dr. Thomas Schröder (IKZ), Prof. Dr. Bernd Rech (HZB), Thomas Frederking (HZB).

The participants after signing the cooperation agreement between IKZ and HZB in corona-conform distance: (from left to right) Dr. Andreas Popp (IKZ), Dr. Manuela Urban (FVB), Dr. Peter Gaal (IKZ), Prof. Dr. Catherine Dubourdieu (HZB), Prof. Dr. Thomas Schröder (IKZ), Prof. Dr. Bernd Rech (HZB), Thomas Frederking (HZB). © Sandra Fischer/HZB

On September 11, 2020, the Helmholtz-Zentrum Berlin (HZB) and the Leibniz-Institut für Kristallzüchtung (IKZ) signed a cooperation agreement to advance joint research on energy and quantum materials. As part of the cooperation, new types of X-ray optics for synchrotron radiation sources are also being developed.

IKZ and HZB share a long history of joint collaboration: IKZ scientists use the BESSY II radiation source from the HZB on a regular basis for their material science studies. In turn, the crystal growers of the IKZ develop and manufacture components that bring out the special properties of BESSY II.

"We are very pleased that we can strengthen our close cooperation with the cooperation agreement,” says Prof. Bernd Rech, scientific director at the HZB. “At BESSY II we offer a variety of x-ray analytical methods for the analysis of complex material systems. As part of our cooperation, we can use our complementary competencies specifically to jointly develop research areas in energy research and quantum technologies.”

Prof. Thomas Schröder, scientific director at the IKZ, also emphasizes the opportunities that the cooperation between the two research institutions allows: “The IKZ is very interested in initiating joint R&D projects on materials for photovoltaics and power electronics with the scientists of the HZB to maximize our impact in this research area.“ Since Prof. Schröder himself spent part of his career in synchrotron research, there is also a personal affinity towards materials and methods development for large-scale research facilities. “Today I am very happy that IKZ can start new R&D projects with BESSY II in order to support the synchrotron sources with our crystalline materials, for example through active and passive X-ray optics.”

Short description of IKZ:

The Leibniz-Institut für Kristallzüchtung in Berlin-Adlershof is an international competence center for science, technology, service and transfer in the field of crystalline materials. The research and development spectrum ranges from basic and applied research to pre-industrial research tasks. The IKZ develops innovations in crystalline materials through its expertise in plant engineering, numerical simulation and crystal growth to achieve crystalline materials of the highest quality with tailored properties. The unique selling point of the institute is the research on volume crystals. This work is accompanied by research and development on nanostructures and thin films as well as strong theoretical and experimental research into materials.

IKZ

  • Copy link

You might also be interested in

  • Key technology for a future without fossil fuels
    Interview
    21.08.2025
    Key technology for a future without fossil fuels
    In June and July 2025, catalyst researcher Nico Fischer spent some time at HZB. It was his sabbatical, he was relieved of his duties as Director of the Catalysis Institute in Cape Town for several months and was able to focus on research only. His institute is collaborating with HZB on two projects that aim to develop environmentally friendly alternatives using innovative catalyst technologies. The questions were asked by Antonia Rötger, HZB.
  • 5000th patient treated with protons for eye tumours
    News
    19.08.2025
    5000th patient treated with protons for eye tumours
    For more than 20 years, Charité – Universitätsmedizin Berlin and the Helmholtz-Zentrum Berlin (HZB) have been jointly offering proton radiation therapy for eye tumours. The HZB operates a proton accelerator in Berlin-Wannsee for this purpose, while Charité provides medical care for the patients. The 5000th patient was treated at the beginning of August.
  • MXene as a frame for 2D water films shows new properties
    Science Highlight
    13.08.2025
    MXene as a frame for 2D water films shows new properties
    An international team led by Dr. Tristan Petit and Prof. Yury Gogotsi has investigated MXene with confined water and ions at BESSY II. In the MXene samples, a transition between localised ice clusters to quasi-two-dimensional water films was identified by increasing temperature. The team also discovered that the intercalated water structure drives a reversible transition from metallic to semiconducting behaviour of the MXene film. This could enable the development of novel devices or sensors based on MXenes.